Resultados da pesquisa - Vaknin-Dembinsky, Adi
- A mostrar 1 - 20 resultados de 24
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
Increased IL-23 secretion and altered chemokine production by dendritic cells upon CD46 activation in patients with multiple sclerosis Por Vaknin-Dembinsky, Adi, Murugaiyan, Gopal, Hafler, David A., Astier, Anne L., Weiner, Howard L.
Publicado em 2008Text -
7
-
8
-
9
Effect of cladribine on COVID-19 serology responses following two doses of the BNT162b2 mRNA vaccine in patients with multiple sclerosis Por Brill, Livnat, Rechtman, Ariel, Zveik, Omri, Haham, Nitzan, Levin, Netta, Shifrin, Alla, Rozenberg, Ayal, Vaknin-Dembinsky, Adi
Publicado em 2022Text -
10
-
11
Sera of Neuromyelitis Optica Patients Increase BID-Mediated Apoptosis in Astrocytes Por Zveik, Omri, Rechtman, Ariel, Haham, Nitzan, Adini, Irit, Canello, Tamar, Lavon, Iris, Brill, Livnat, Vaknin-Dembinsky, Adi
Publicado em 2022Text -
12
Cerebrospinal fluid of progressive multiple sclerosis patients reduces differentiation and immune functions of oligodendrocyte progenitor cells Por Zveik, Omri, Fainstein, Nina, Rechtman, Ariel, Haham, Nitzan, Ganz, Tal, Lavon, Iris, Brill, Livnat, Vaknin‐Dembinsky, Adi
Publicado em 2022Text -
13
Circulating microRNAs as biomarkers for rituximab therapy, in neuromyelitis optica (NMO) Por Vaknin-Dembinsky, Adi, Charbit, Hanna, Brill, Livnat, Abramsky, Oded, Gur-Wahnon, Devorah, Ben-Dov, Iddo Z., Lavon, Iris
Publicado em 2016Text -
14
Effectiveness of multi-disciplinary rehabilitation for patients with Neuromyelitis Optica Por Nechemia, Yael, Moreh, Elior, Weingarden, Harold, Bloch, Ayala, Givon, Uri, Vaknin-Dembinsky, Adi, Schwartz, Isabella, Meiner, Zeev, Zeilig, Gabi
Publicado em 2016Text -
15
Suppression of neuroinflammation by an allosteric agonist and positive allosteric modulator of the α7 nicotinic acetylcholine receptor GAT107 Por Mizrachi, Tehila, Marsha, Oshrit, Brusin, Karen, Ben-David, Yael, Thakur, Ganesh A., Vaknin-Dembinsky, Adi, Treinin, Millet, Brenner, Talma
Publicado em 2021Text -
16
Severe Acute Respiratory Syndrome Coronavirus 2 Third Vaccine Immune Response in Multiple Sclerosis Patients Treated with Ocrelizumab Por Brill, Livnat, Raposo, Catarina, Rechtman, Ariel, Zveik, Omri, Levin, Netta, Oiknine‐Djian, Esther, Wolf, Dana G., Vaknin‐Dembinsky, Adi
Publicado em 2022Text -
17
Longitudinal humoral response in MS patients treated with cladribine tablets after receiving the second and third doses of SARS-CoV-2 mRNA vaccine() Por Brill, Livnat, Rechtman, Ariel, Shifrin, Alla, Rozenberg, Ayal, Afanasiev, Svetlana, Zveik, Omri, Haham, Nitzan, Levin, Neta, Vaknin-Dembinsky, Adi
Publicado em 2022Text -
18
NMO-IgG and AQP4 Peptide Can Induce Aggravation of EAMG and Immune-Mediated Muscle Weakness Por Mizrachi, Tehila, Brill, Livnat, Rabie, Malcolm, Nevo, Yoram, Fellig, Yakov, Zur, Mayan, Karussis, Dimitrios, Abramsky, Oded, Brenner, Talma, Vaknin-Dembinsky, Adi
Publicado em 2018Text -
19
Age-Related Clinical Presentation of MOG-IgG Seropositivity in Israel Por Brill, Livnat, Ganelin-Cohen, Esther, Dabby, Ron, Rabinowicz, Shira, Zohar-Dayan, Efrat, Rein, Netaniel, Aloni, Eyal, Karmon, Yuval, Vaknin-Dembinsky, Adi
Publicado em 2021Text -
20
Humoral and T-Cell Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Ocrelizumab Por Brill, Livnat, Rechtman, Ariel, Zveik, Omri, Haham, Nitzan, Oiknine-Djian, Esther, Wolf, Dana G., Levin, Netta, Raposo, Catarina, Vaknin-Dembinsky, Adi
Publicado em 2021Text